WHAT'S NEW IN CPS
Check out our latest content updates
CPhA is thrilled to share with you the latest additions and updates in CPS.
Content updates
Major updates
The following content has been extensively updated and reviewed by 2 external peer reviewers:
- Asthma in Infants and Children: Clarified and emphasized appropriate use of short-acting beta-agonists (>2 times per week is a sign of suboptimal control); added information and reference to Canadian scoring system for exacerbation management, the Pediatric Respiratory Assessment Measure (PRAM); added information and reference to Canadian Pediatric Society guidelines on exacerbation management.
- Edema: New table: Examples of Drugs that Can Cause Edema.
- Excessive Perspiration and Body Odour: New patient infographic available in English and French; added information and reference to Canadian rating system, the Hyperhidrosis Disease Severity Scale (HDSS).
- Gout and Hyperuricemia: New patient infographic available in English.
Minor updates
The following content has been reviewed to ensure that it is current:
- COVID-19: Updated the chapter to reflect current understanding and to make it more streamlined, guideline-driven and user-friendly.
- Dermatological Considerations in Skin of Colour: Routine review.
- Bacterial meningitis: Updated information on use of adjunctive corticosteroids; updated drug table entry for meningococcal vaccines.
- Serum Drug Concentration Monitoring: Added Hartford nomogram for once-daily aminoglycoside dosing; added information on AUC-based dosing for vancomycin.
- Pruritis: Routine review.
- Rosacea: Routine review.
Check out what’s new in CPS to learn more.
